Senores Pharmaceuticals has entered into the Share Purchase agreement (SPA) with certain shareholders (Public Category) of Havix Group Inc. D/B/A Aavis Pharmaceuticals (Havix) for acquisition of 8454 equity shares of Havix aggregating to 3.73% of the total paid up share capital of Havix and subject to the terms and conditions as mentioned in the SPA.
Further, post the aforesaid acquisition, the shareholding of the Company in Havix will increase from 51.23% to 54.96%. The said acquisition will be completed within the period of 10 days from the date of execution of SPA.
Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: